Integrichain Blog

Blog

Contracts & Pricing Olivia Nweze Gourab Khan Ben Fanelli
February 24, 2022

Branded Pharma Fee: Manufacturer Considerations

5 Minute Read

And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.

ICyte Platform Josh Halpern
February 15, 2022

Unifying IntegriChain’s Services & Support: Data Management

4 Minute Read

President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.

Gross-to-Net Jen Sharpe
February 3, 2022

Forecasting for the Future

2 Minute Read

How manufacturers can leverage successful returns and inventory pipeline reserve methodologies for long-term benefits.

Contracts & Pricing Gourab Khan
January 24, 2022

New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B

4 Minute Read

Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.

Corporate Kevin E. Leininger
January 20, 2022

IntegriChain and Blue Fin Group Combine Forces

2 Minute Read

Our newly combined team of commercialization experts focuses on solving your biggest access challenges: patient funnel pull-through and GTN optimization.

Launch Readiness Leigh Anne Siino
January 19, 2022

Best Practices: Redesigning the Perfect Launch

3 Minute Read

We ask market access leaders what they would change if they had the ability to launch their therapy all over again.

Channel Aaron Light Umber Afshan
January 13, 2022

Frequently Asked Questions: Channel and Revenue Leakage

3 Minute Read

We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.

Channel Olivia Nweze Tim Keys
December 20, 2021

Retail Pharmacy’s Digital Transformation

3 Minute Read

As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?

ICyte Platform Josh Halpern
November 23, 2021

A Look Back at the 2021 Access Insights Conference

2 Minute Read

Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper